Welcome to YLOAN.COM
yloan.com » aarkstore » Arca Biopharma, Inc. (abio) - Financial And Strategic Analysis Review --- Aarkstore Enterprise
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Arca Biopharma, Inc. (abio) - Financial And Strategic Analysis Review --- Aarkstore Enterprise

ARCA biopharma, Inc

ARCA biopharma, Inc. (ABIO) - Financial and Strategic Analysis Review

ARCA biopharma, Inc. (ARCA biopharma) is a biopharmaceutical company, engaged in the development and commercializing genetically-targeted therapies for the treatment of heart failure and other cardiovascular diseases. Its technology platform combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. The company has discovered genetic variations in two cardiac receptors that interact with bucindolol's unique pharmacology. The company's product candidate, Gencaro (bucindolol hydrochloride) is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications.

ARCA biopharma, Inc. Key Recent Developments

Mar 26, 2010: ARCA biopharma Receives Patent For Bucindolol


Mar 17, 2010: ARCA Receives Nasdaq Notice Per Nasdaq Rule 5810(b)

Dec 22, 2009: ARCA Submits Request For SPA For Gencarotm

Dec 22, 2009: ARCA Submits Study Protocol For Heart Failure Drug

Nov 23, 2009: Arca Obtains FDA Fast Track Designation For Gencaro

This comprehensive SWOT profile of ARCA biopharma, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ARCA biopharma, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.


- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit :

http://www.aarkstore.com/reports/ARCA-biopharma-Inc-ABIO-Financial-and-Strategic-Analysis-Review-51686.html

by: Aarkstore Enterprise
Shanghai Chlor Alkali Chemical Co Ltd 900908 Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-- Survey Of Ethoxylate In China Aarkstore Enterprise-- Yellow Phosphorus Export Situation In China Aarkstore Enterprise--yellow Phosphorus Export In China 2008-q1 2009 Aarkstore Enterprise---world Outlook Of Glyphosate 2009-2014 Aarkstore Enterprise--survey Of Glufosinate In China Aarkstore Enterprise-- The Survey Of 2,4-d In China Aarkstore Enterprise---the Survey Of Sorbitol In Asia Pacific Aarkstore Enterprise--2010 U.s. Cd, Record & Tape Recording Industry Report Aarkstore Enterprise--2010 U.s. Cement Manufacturing Industry Report Aarkstore Enterprise -carbon Trading And The Effect Of The Copenhagen Agreement: Technical Options Aarkstore Enterprise-2010 U.s. Construction Machinery Manufacturing Industry Report China Applied Meters Mfg. Industry Profile - Cic4119 --- Aarkstore Enterprise
print
www.yloan.com guest:  register | login | search IP(216.73.216.61) California / Anaheim Processed in 0.017843 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 52 , 3760, 353,
Arca Biopharma, Inc. (abio) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Anaheim